Thioredoxin Reductase Assay Kit

 kit sufficient for 100 assays (1 mL)

Pricing and availability is not currently available.

Quality Level


 kit sufficient for 100 assays (1 mL)

shipped in

dry ice

storage temp.


Gene Information

human ... TXNRD1(7296), TXNRD2(10587), TXNRD3(114112)

General description

The Thioredoxin Reductase Assay Kit uses a colorimetric assay for the determination of thioredoxin reductase activity in mammalian cells and tissues. It is based on the reduction of 5,5′-dithiobis(2-nitrobenzoic) acid (DTNB) with NADPH to 5-thio-2-nitrobenzoic acid (TNB) that produces a strong yellow color that is measured at 412 nm.



Using post nuclear extracts of rat liver, the kit shows linearity up to 0.25 units per mL. In this preparation, ~20% of the activity is due to non-specific reductase activity (refractory to the TrxR inhibitor).

Features and Benefits

  • An easy and simple method
  • The kit contains all the reagents required for a colorimetric assay of mammalian thioredoxin reductase
  • The kit includes an inhibitor solution for specific inhibition of mammalian thioredoxin reductase
  • The kit has been tested with heart muscle, as well as lysates from cell lines such as HeLa, A549, Jurkat, U937, A431, COS, CHO, and NIH 3T3 cells

Kit Components Only

Product No.

  • Assay Buffer 5x for Thioredoxin Reductase 30 mL

  • Thioredoxin Reductase 10 μg

  • Thioredoxin Reductase Inhibitor Solution .05 mL

  • 5,5'-Dithiobis(2-nitrobenzoic) acid (DNTB) 150 mg

  • NADPH 25 mg

  • Dimethyl Sulfoxide (DMSO) 7.5 mL


Health hazard

Signal Word


Hazard Statements


NONH for all modes of transport

WGK Germany


Flash Point(F)

188.6 °F

Flash Point(C)

87 °C

Certificate of Analysis
Certificate of Origin
Ida Landini et al.
Journal of inorganic biochemistry, 208, 111079-111079 (2020-06-05)
The antiproliferative properties of a series of structurally-related gold(I) and silver(I) linear complexes inspired to the clinically established gold-based drug auranofin were investigated in A2780 ovarian cancer cells and in their auranofin (A2780/AF-R) and cisplatin (A2780/CDDP-R) resistant counterparts. In A2780...
Iwona Jarocka-Karpowicz et al.
Biomolecules, 10(3) (2020-03-04)
Psoriasis is a chronic inflammatory skin disease characterized by dysregulated keratinocyte differentiation, but oxidative stress also plays an important role in the pathogenesis of this disease. Here, we examined the effect of cannabidiol (CBD), a phytocannabinoid with antioxidant and anti-inflammatory...
Jennifer E Hrabe et al.
Redox biology, 5, 319-327 (2015-06-27)
Transforming growth factor β-activated kinase 1 (TAK1) is critical for survival of many KRAS mutated colorectal cancer cells, and TAK1 inhibition with 5Z-7-oxozeaenol has been associated with oxidative stress leading to tumor cell killing. When SW 620 and HCT 116...
Danilo Grünig Humberto da Silva et al.
Toxicology in vitro : an international journal published in association with BIBRA, 56, 62-74 (2019-01-18)
This study investigated the effects of incubation period and melatonin treatment on red blood cell (RBC) metabolism in an auto-incubation model of H2O2-induced oxidative stress. The study was carried out on three healthy adult donors by incubating RBCs in their...
Ming Luo et al.
Cell metabolism, 28(1), 69-86 (2018-07-05)
Although breast cancer stem cells (BCSCs) display plasticity transitioning between quiescent mesenchymal-like (M) and proliferative epithelial-like (E) states, how this plasticity is regulated by metabolic or oxidative stress remains poorly understood. Here, we show that M- and E-BCSCs rely on...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.